search
Back to results

Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy

Primary Purpose

HIV/AIDS

Status
Completed
Phase
Phase 1
Locations
United States
Study Type
Interventional
Intervention
APPEAL
Sponsored by
State University of New York - Downstate Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV/AIDS

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Receiving HIV care at site of recruitment
  • Prescribed an HIV antiretroviral regimen
  • HIV RNA viral load less than 200 copies/mL in last six months

Exclusion Criteria:

  • Unable to communicate in English
  • Prior participation in formative components of the study
  • Plans to move outside of New York City in next six months
  • Has cognitive impairment that would limit ability to provide informed consent

Sites / Locations

  • SUNY Downstate Health Sciences University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

APPEAL Program

Standard of care

Arm Description

Participants receive the APPEAL program, consisting of three one-on-one sessions, each lasting approximately one hour, and spaced one month apart. Sessions are designed to promote positive affect. Participants receive optional weekly check-ins to support behavior change efforts. All participants continue to receive standard of care.

Participants receive standard of care.

Outcomes

Primary Outcome Measures

Feasibility of recruitment approaches
The percentage of eligible individuals consented and randomized
Feasibility of retention methods
The percentage of enrolled individuals who complete baseline, three-month, and six-month self-report evaluation measures
Acceptability of intervention
The percentage of individuals in the intervention condition who complete all three sessions
Changes in the proposed mechanistic target of positive and negative emotions, assessed using the Positive and Negative Affect Scale (PANAS)
The PANAS is a 20 item measure which assesses emotions utilizing 5 response options for each question, ranging in value from 1 to 5. PANAS includes two 10-item subscales: positive affect and negative affect. Positive affect and negative affect items are summed separately, with each subscale ranging from 10 to 50. Higher scores for positive affect subscale indicate higher levels of positive affect and lower scores for negative affect items indicate lower levels of negative affect

Secondary Outcome Measures

Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Modified Differential Emotions Scale (MDES).
The MDES is a 20 item measure which assesses emotions utilizing 5 response options for each question, ranging in value from 0 to 4. MDES includes two 10-item subscales: positive affect and negative affect. Positive affect and negative affect items are summed separately, and each is divided by 10, with each subscale ranging from 0 to 4. Higher score for each subscale indicate greater frequency of experiencing positive or negative emotions.
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Drug Abuse Screening Test (DAST 10)
The DAST 10 is a 10 item screen for drug abuse. It includes 10 items, each response with a 0 or 1. Items are summed, with a range of responses from 0 to 10. Higher scores indicate greater negative consequences of drug abuse.
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Perceived Stress Scale (PSS4)
The PSS4 measures perceived stress. Each of the 4 items has five possible response options, ranging from 0 to 4. The resulting summed scale can range from 0 to 16, with higher scores indicating greater stress.
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Coping Strategies Inventory, Short Form (CSISF)
The CSISF is a 16 item scale assessing approaches to coping with stressors. Each of the items has 5 potential response options, ranging from 1 to 5, and items are grouped into four 4-item subscales. Items within each subscale are summed, resulting in a subscale range from 4 to 20. Higher scores on each of the subscales, focused on 1) Problem-Focused Engagement, (2) Problem-Focused Disengagement, (3) Emotion-Focused Engagement, and (4) Emotion-Focused Disengagement, indicates greater frequency of use of that particular coping strategy.
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Revised Life Orientation Test (LOT-R)
The LOT-R is a 6-item measure of generalized optimism versus pessimism. For each of the items there are 5 response options ranging from 0 to 4. Items are summed with a scale range of 0 to 24, and with higher scores indicating greater optimism.
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Patient Health Questionnaire-8 item (PHQ8)
The PHQ8 is an 8-item measure assessing burden of depression symptoms. Each item has 4 response options ranging from 0 to 3; items are summed with a resulting scale range of 0 to 24. Higher scores suggest greater risk for depression.
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Alcohol Use Disorders Identification Test - Concise (AUDIT-C)
The AUDIT-C is a 3-item measure assessing risk for alcohol use disorder. Each item has 4 response options ranging from 0 to 4, and items are summed with a resulting range from 0 to 12. In men, a score of 4 or more is considered positive for an alcohol use disorder; in women, a score of 3 or more is considered positive.
Frequency of endorsement of stressful life events utilizing a modification of the Crisis in Family Systems (CRYSIS)
An adapted version of the CRISYS checklist is being utilized, based on formative feedback on the scale. The adapted measure lists thirty-four events, with a 0 indicating no experience and a 1 indicating an experience. The checklist can range from 0 to 34 possible events.
Self-reported values of percent adherence
Single item asking over past 30 days how often medication was taken as prescribed. Four response options available: 100%, 95-99% 75-94%, less than 75%
Self-reported adherence with medication taking instructions
Single item asking over past 30 days how good of a job did participant do at take medication in the way that they are supposed to. Six response options available: Very poor, poor, fair, good, very good, excellent
Self-reported adherence missed doses of medication
Single item asking number of days in the past 30 days that participant missed at least one dose of medication
Feasibility of electronic medication adherence
Proportion of participants who utilize Wisepill throughout study participation
HIV RNA viral load
Chart review will be conducted to assess HIV RNA viral load
Retention in care
Chart review will be conducted to assess kept and missed study visits

Full Information

First Posted
July 23, 2019
Last Updated
October 25, 2021
Sponsor
State University of New York - Downstate Medical Center
Collaborators
National Institute of Nursing Research (NINR)
search

1. Study Identification

Unique Protocol Identification Number
NCT04035759
Brief Title
Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy
Official Title
Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy (Project APPEAL)
Study Type
Interventional

2. Study Status

Record Verification Date
October 2021
Overall Recruitment Status
Completed
Study Start Date
October 16, 2019 (Actual)
Primary Completion Date
April 26, 2021 (Actual)
Study Completion Date
April 26, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
State University of New York - Downstate Medical Center
Collaborators
National Institute of Nursing Research (NINR)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study assesses the feasibility and acceptability of the APPEAL program, a 3-session intervention designed to promote positive affect among men and women living with HIV infection. Forty participants will be randomly assigned to receive the APPEAL program, and another 40 will receive standard of care. All participants will complete self-reported assessments at baseline and at 3 and 6 months, and will have their HIV antiretroviral medication adherence monitored as part of study participation.
Detailed Description
There is strong reason to expand the scope of current adherence programs to include consideration of a group of health protective variables known as 'psychosocial assets'. These assets include cognitive factors, such as optimism, emotional factors, such as positive affect, and positive social relationships. Increased psychosocial assets such as positive affect are associated with reduced morbidity and mortality, slower slower HIV progression, and reduced burden of depression symptoms. However, there has been limited translation of positive affect interventions to support patient self-management. In this study, we extend previous research on positive affect and adherence through the APPEAL program. The Affect, Promoting Positive Engagement, and Adherence for Life (APPEAL) program is an intervention that combines positive affect approaches to promote adherence in patients who have suboptimal adherence. We seek to implement the program, assess its feasibility, and describe associations with theoretically derived mechanisms of change, including positive affect.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV/AIDS

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
20 (Actual)

8. Arms, Groups, and Interventions

Arm Title
APPEAL Program
Arm Type
Experimental
Arm Description
Participants receive the APPEAL program, consisting of three one-on-one sessions, each lasting approximately one hour, and spaced one month apart. Sessions are designed to promote positive affect. Participants receive optional weekly check-ins to support behavior change efforts. All participants continue to receive standard of care.
Arm Title
Standard of care
Arm Type
No Intervention
Arm Description
Participants receive standard of care.
Intervention Type
Behavioral
Intervention Name(s)
APPEAL
Intervention Description
Three-session, individually administered program, with sessions spaced monthly. Optional weekly contacts with participants to support engagement in program exercises/activities.
Primary Outcome Measure Information:
Title
Feasibility of recruitment approaches
Description
The percentage of eligible individuals consented and randomized
Time Frame
Baseline to 6 months
Title
Feasibility of retention methods
Description
The percentage of enrolled individuals who complete baseline, three-month, and six-month self-report evaluation measures
Time Frame
Baseline to 3 months
Title
Acceptability of intervention
Description
The percentage of individuals in the intervention condition who complete all three sessions
Time Frame
Baseline to 6 months
Title
Changes in the proposed mechanistic target of positive and negative emotions, assessed using the Positive and Negative Affect Scale (PANAS)
Description
The PANAS is a 20 item measure which assesses emotions utilizing 5 response options for each question, ranging in value from 1 to 5. PANAS includes two 10-item subscales: positive affect and negative affect. Positive affect and negative affect items are summed separately, with each subscale ranging from 10 to 50. Higher scores for positive affect subscale indicate higher levels of positive affect and lower scores for negative affect items indicate lower levels of negative affect
Time Frame
Baseline, 3 months, 6 months
Secondary Outcome Measure Information:
Title
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Modified Differential Emotions Scale (MDES).
Description
The MDES is a 20 item measure which assesses emotions utilizing 5 response options for each question, ranging in value from 0 to 4. MDES includes two 10-item subscales: positive affect and negative affect. Positive affect and negative affect items are summed separately, and each is divided by 10, with each subscale ranging from 0 to 4. Higher score for each subscale indicate greater frequency of experiencing positive or negative emotions.
Time Frame
Baseline, 3 months, 6 months
Title
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Drug Abuse Screening Test (DAST 10)
Description
The DAST 10 is a 10 item screen for drug abuse. It includes 10 items, each response with a 0 or 1. Items are summed, with a range of responses from 0 to 10. Higher scores indicate greater negative consequences of drug abuse.
Time Frame
Baseline, 3 months, 6 months
Title
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Perceived Stress Scale (PSS4)
Description
The PSS4 measures perceived stress. Each of the 4 items has five possible response options, ranging from 0 to 4. The resulting summed scale can range from 0 to 16, with higher scores indicating greater stress.
Time Frame
Baseline, 3 months, 6 months
Title
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Coping Strategies Inventory, Short Form (CSISF)
Description
The CSISF is a 16 item scale assessing approaches to coping with stressors. Each of the items has 5 potential response options, ranging from 1 to 5, and items are grouped into four 4-item subscales. Items within each subscale are summed, resulting in a subscale range from 4 to 20. Higher scores on each of the subscales, focused on 1) Problem-Focused Engagement, (2) Problem-Focused Disengagement, (3) Emotion-Focused Engagement, and (4) Emotion-Focused Disengagement, indicates greater frequency of use of that particular coping strategy.
Time Frame
Baseline, 3 months, 6 months
Title
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Revised Life Orientation Test (LOT-R)
Description
The LOT-R is a 6-item measure of generalized optimism versus pessimism. For each of the items there are 5 response options ranging from 0 to 4. Items are summed with a scale range of 0 to 24, and with higher scores indicating greater optimism.
Time Frame
Baseline, 3 months, 6 months
Title
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Patient Health Questionnaire-8 item (PHQ8)
Description
The PHQ8 is an 8-item measure assessing burden of depression symptoms. Each item has 4 response options ranging from 0 to 3; items are summed with a resulting scale range of 0 to 24. Higher scores suggest greater risk for depression.
Time Frame
Baseline, 3 months, 6 months
Title
Measurement properties (range, missingness, reliability) and mean scores with standard deviations for the Alcohol Use Disorders Identification Test - Concise (AUDIT-C)
Description
The AUDIT-C is a 3-item measure assessing risk for alcohol use disorder. Each item has 4 response options ranging from 0 to 4, and items are summed with a resulting range from 0 to 12. In men, a score of 4 or more is considered positive for an alcohol use disorder; in women, a score of 3 or more is considered positive.
Time Frame
Baseline, 3 months, 6 months
Title
Frequency of endorsement of stressful life events utilizing a modification of the Crisis in Family Systems (CRYSIS)
Description
An adapted version of the CRISYS checklist is being utilized, based on formative feedback on the scale. The adapted measure lists thirty-four events, with a 0 indicating no experience and a 1 indicating an experience. The checklist can range from 0 to 34 possible events.
Time Frame
Baseline, 3 months, 6 months
Title
Self-reported values of percent adherence
Description
Single item asking over past 30 days how often medication was taken as prescribed. Four response options available: 100%, 95-99% 75-94%, less than 75%
Time Frame
Baseline, 3 months, 6 months
Title
Self-reported adherence with medication taking instructions
Description
Single item asking over past 30 days how good of a job did participant do at take medication in the way that they are supposed to. Six response options available: Very poor, poor, fair, good, very good, excellent
Time Frame
Baseline, 3 months, 6 months
Title
Self-reported adherence missed doses of medication
Description
Single item asking number of days in the past 30 days that participant missed at least one dose of medication
Time Frame
Baseline, 3 months, 6 months
Title
Feasibility of electronic medication adherence
Description
Proportion of participants who utilize Wisepill throughout study participation
Time Frame
Baseline through 6 months
Title
HIV RNA viral load
Description
Chart review will be conducted to assess HIV RNA viral load
Time Frame
Baseline through 6 months
Title
Retention in care
Description
Chart review will be conducted to assess kept and missed study visits
Time Frame
Baseline through six months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Receiving HIV care at site of recruitment Prescribed an HIV antiretroviral regimen HIV RNA viral load less than 200 copies/mL in last six months Exclusion Criteria: Unable to communicate in English Prior participation in formative components of the study Plans to move outside of New York City in next six months Has cognitive impairment that would limit ability to provide informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tracey Wilson, PhD
Organizational Affiliation
SUNY Downstate Health Sciences University
Official's Role
Principal Investigator
Facility Information:
Facility Name
SUNY Downstate Health Sciences University
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11231
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Raw, de-identified data and codebook related to primary outcomes will be made available on Open Science Framework. Wilson, T. (2019, July 21). Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy. Retrieved from osf.io/s7ve9
IPD Sharing Time Frame
Data will become available upon completion of publication of outcomes paper associated with the study. Data will be made available for three years following publication.
IPD Sharing Access Criteria
Principal Investigator wil grant permission upon request
IPD Sharing URL
http://osf.io/s7ve9
Citations:
PubMed Identifier
32833478
Citation
Wilson TE, Massiah C, Radigan R, DeHovitz J, Govindarajulu US, Holman S, Melendez M, Yusuff J, Taylor T. The positive affect, promoting Positive Engagement, and Adherence for Life (APPEAL) feasibility trial: Design and rationale. Health Psychol. 2020 Sep;39(9):767-775. doi: 10.1037/hea0000880.
Results Reference
derived

Learn more about this trial

Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy

We'll reach out to this number within 24 hrs